跳至主要内容
临床试验/CTRI/2018/06/014537
CTRI/2018/06/014537招募中未知

A prospective, observational study to assess the effects of SSRI and SNRI on cognitive function in patients of Major Depressive Disorders (MDD)

Department of Pharmacology IPGMER0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1)Adult patients (18 years to 50 years) of either gender attending psychiatry OPD at IOP,
  • with a clinical diagnosis of Major Depressive Disorder as per ICD10 criteria.
  • 2)Subjects of MDD must be in remission phase with a Hamilton Depressive Rating Score (HAM-D 17) of <7) at enrolment and taking any of the following SSRIs - fluoxetine, sertraline, escitalopram and/or SNRI like mirtazapine for at least last 6 months. Patients who are additionally on cognitive behavioral therapy (CBT) as part of their treatment shall also be included.
  • 3)Subjects should have at least 8 years of formal school education in order to undertake the cognitive function tests.
  • 4)Subjects or their care givers should be willing to give written informed.

排除标准

  • 1)History of post traumatic or Obsessive compulsive Disorder (OCD)
  • 2)History of schizophrenia, psychosis or bipolar delusional disorder
  • 3)History of intake of any drugs that are likely to have effect on cognition (anticonvulsants, sedative hypnotics, neuroleptics, opioids)
  • 4)History of addictions- alcohol, substance abuse

研究者

发起方
Department of Pharmacology IPGMER

相似试验

Effect of SSRI and SNRI on various mental activities... | 临床试验